Therapeutic perspectives of HIV infection and of opportunistic infections. Multicenter projects of clinical investigation in the EEC.
DOI:
https://doi.org/10.20344/amp.4474Abstract
Some centers in Portugal involved in the treatment of AIDS patients collaborate in clinical research programmes at a European level. The European Network for the Treatment of AIDS (ENTA) is a concerted action, with logistical and political support from the European Community. Four prospective European multicentre trials on opportunist infections in AIDS patients, have been implemented since the beginning of the ENTA, and 45 European centres, belonging to 11 countries, including Portugal, are so far involved in the present Trials in the Treatment and Prophylaxis of Tuberculosis and Toxoplasmosis. EUROAIDS is another concerted action whose aim is a retrospective study on opportunist infections and cancers related with AIDS registered in several countries in Europe, from 1979 to 1989, and correlate these data with demographic and clinical aspects. Another multicentric trial on antiretroviral treatment, The Iberian ddI study, started and several Spanish and Portuguese centres enrolled patients in this study.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
